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We have previously demonstrated that administration of an- 
tisera against NGF (anti-NGF) can have profound effects on 
developing primary afferents (Flitter et al., 1991). Chronic 
administration of anti-NGF to rats beginning on the day of 
birth results in a severe depletion of cutaneous Ab high- 
threshold mechanoreceptors (HTMRs) from the surai nerve. 
Here we have carried out further experiments in order to 
define the period of time over which this change in the cu- 
taneous afferent population can be produced, and to inves- 
tigate a possible mechanism for the change. Treatment with 
anti-NGF from postnatal day (PND) O-14 resulted in a de- 
pletion of cutaneous A6 HTMRs from the surai nerve and also 
a 20% loss of sensory neurons. However, treatment from 
PND 2-14 produced an identical deficit of HTMRs without 
any accompanying ceil death. Thus, the depletion of cuta- 
neous Ab HTMRs can be achieved in the absence of ceil 
death induced by anti-NGF treatment. it was also found that 
a 7 d treatment from PND 4-l 1 was sufficient to reproduce 
this effect, but that 7 d treatments earlier (PND 2-9) or later 
(PND 7-14) within the first 2 weeks were much less effective. 
This critical period, PND 4-l 1, corresponds to a period of 
anatomical change in the innervation of the skin, from epi- 
dermai innervation to primarily dermai innervation (Fitzger- 
aid, 1967; Reynolds et al., 1991). in every case where anti- 
NGF treatment reduced the proportion of HTMRs, there was 
a reciprocal increase in the proportion of sensitive A6 hair 
follicle (D-hair) afferents. We hypothesize that in the ab- 
sence of NGF, developing cutaneous A& HTMRs do not die 
but innervate novel targets in the dermis and become D-hair 
afferents instead. 
The development of rat sensory neurons continues well after 
birth and is not completed until at least 14 d postnatally (PND 
14). Responses in primary afferents can be elicited by stimu- 
lation of the skin as early as embryonic day 16 (E 16) (Fitzgerald, 
1987a). On the day of birth, slowly adapting and rapidly adapt- 
ing afferents can be distinguished, but responses are not mature 
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and do not resemble those of the adult until the second postnatal 
week (Fitzgerald, 1987b). 
Somal spike shape also does not mature until PND 14. On 
PND 1, all cells have long-duration action potentials with an 
inflection on the falling phase. By PND 14, spikes in cells with 
unmyelinated axons (C-neurons) look much the same, but action 
potential duration has shortened a great deal in A-neurons, and 
most have lost the inflection (Fulton, 1987). This period between 
birth and 14 d also corresponds to the time during which pe- 
ripheral myelination is completed (Friede and Samorajske, 1968). 
NGF is necessary in utero for the development of most sen- 
sory neurons (Johnson et al., 1980). While not required for 
survival in the adult, around 50% of sensory neurons maintain 
high affinity receptors (Richardson et al., 1986) and continue to 
transport NGF retrogradely throughout adult life (Thoenen and 
Barde, 1980). It has been reported that administration of NGF 
antisera beginning on the day of birth leads to the death of 
between 18 and 38% of sensory neurons. The cells that are lost 
after this treatment are primarily the small C neurons (Yip et 
al., 1984; Hulsebosch et al., 1987). Exposure to antibodies against 
NGF in the adult produces no cell death (Gorin and Johnson, 
1980; Schwartz et al., 1982), but it is not known when during 
development the dependence on NGF for survival ends. 
We have demonstrated previously (Ritter et al., 1991) that 
chronic administration of NGF antisera beginning on the day 
of birth causes a change in the physiology of A6 cutaneous 
afferents, thinly myelinated afferents that in the young adult rat 
conduct between 2-14 m/set. Normally, the majority of A6 
afferents in the sural nerve innervate cutaneous high-threshold 
mechanoreceptors (HTMRs) and respond to noxious mechan- 
ical stimulation of the skin. After NGF deprivation beginning 
on the day of birth, most Ab afferents innervate D-hairs, low- 
threshold mechanoreceptors that are exquisitely sensitive to hair 
movement (Burgess and Perl, 1967; Lynn and Carpenter, 1982). 
We have suggested that this change may not be due simply to 
selective death of developing HTMRs caused by anti-NGF 
treatment, but might involve redirection of fibers that would 
have become HTMRs to innervate D-hairs instead. Here we 
further define the period during which anti-NGF treatment can 
alter the composition of the sural nerve, and examine more 
closely the issue of whether cell death can be responsible for 
this change. 
Portions of these data have been presented in short form 
(Lewin et al., 1991a; Mendell et al., 1991; Ritter et al., 1991). 
Materials and Methods 
Two antisera were raised in adult rabbits against mouse 2.5s NGF and 
used interchangeably throughout these experiments. Sera were tested 
for their ability to block NGF-induced neurite outgrowth in PC1 2 cells 
The Journal of Neuroscience, May 1992. 12(5) 1897 
Electrical 
SIimulation 
Collision 
2mwc 
Pinch 
,..../ 
10 set 
(Greene, 1977a) and to recognize NGF on Western blots. At the end of 
the series of experiments, the bioassay was repeated, and both sera were 
still able to block the effects of 50 &ml of NGF at a concentration of 
l/1000. 
Sprague-Dawley rats of either sex were injected for various times with 
antisera (5 pVgm, s.c.) every day for the first 7 d, and then every other 
day for the duration of the treatment. The day of birth was denoted 
PND 0, and treatments were given from PND O-14, PND 2-14, PND 
2-9, PND 4-l 1, or PND 7-14. Additionally, data are included from 
animals treated from birth to 5 weeks of age, animals treated from 0 to 
5 weeks and allowed to survive untreated for an additional 3 weeks, 
and animals treated from 2 to 5 weeks of age (Ritter et al., 1991). 
Recordings were made from at least three animals in each treatment 
group, and control data were taken from untreated age-matched animals. 
Usually about 15 units were characterized in each animal so that the 
afferents recorded in each animal contributed equally to the total. It 
was noted that the proportions of afferent types in individual animals 
always approximated those found for the entire group (Ritter et al., 
1991). 
Electrophysiological recordings were made under urethane anesthesia 
(1.25 gm/kg) after the animals had reached 5-8 weeks of age. A lami- 
nectomy was performed to expose the entire L5 dorsal root and re- 
cordings were made in teased dorsal root filaments of single units driven 
by sural nerve stimulation as described previously (Lewin and McMa- 
hon, 1991). Each single unit activated by electrical stimulation of the 
sural nerve was characterized as to adequate stimulus (Horch et al., 
1977) with the aid of a dissecting microscope so that individual hairs 
could be manipulated. Conduction velocity, receptive field size and 
location, and von Frey threshold were also noted. For cutaneous HTMRs, 
von Frey thresholds were always determined from the most sensitive 
spot in the receptive field, and for slowly adapting HTMRs, threshold 
was considered to be the lowest value of force that would produce a 
slowly adapting discharge. In the rat, cutaneous HTMRs in hairy skin 
do not respond well to heat (Lynn and Shakhanbeh, 1988); therefore, 
responses to heat were not tested in these experiments. The ability of 
naturally evoked impulses to abolish electrically evoked impulses due 
to refractoriness was tested to confirm further that they were generated 
in the same afferent (Fig. 1). 
Afl afferents (those with conduction velocities greater than 14 m/set) 
were consistently sampled in only three treatment groups: control, O-5 
weeks treatment, and treatment from 0 to 5 weeks with an additional 
Figure 1. Extracellular recordings were 
made from teased dorsal root filaments 
of units driven by sural nerve stimu- 
lation. Three units were present in this 
strand that were easily distinguishable 
on the basis of the size and shape of 
their spikes (top record). The slowest- 
conducting (5.5 m&c), and smallest, 
unit was identified as a cutaneous 
HTMR. The middle trace shows two 
superimposed traces before and after 
natural stimulation of the receptive field 
in the periphery (in this case, pinching 
of the receptive field). The nerve was 
stimulated at high frequencies (5-10 Hz) 
to increase the chance that a naturally 
evoked spike would abolish an electri- 
cally evoked spike due to refractoriness. 
The asterisk indicates the naturally 
evoked spike, which in this case abol- 
ished the spike evoked by nerve stim- 
ulation. The bottom trace shows the 
same unit in response to pinch of its 
receptive field. This was an examnle of 
a cbtaneous HTMR with a slowly 
adapting discharge. The gain in the bot- 
tom record is twice that of the top two 
records. 
3 weeks without treatment. After it became apparent that there was no 
change in A0 physiology (see Results), only A6 afferents (conduction 
velocity between 2 and 14 m/set) were characterized in subsequent 
experimental groups. However, in every experiment across all treatment 
groups, an attempt was made to characterize every unit with a latency 
appropriate for A6 conduction velocity. Since the criterion for selecting 
units was latency to electrical stimulation and not response to natural 
stimulation, we consider that our sample accurately reflects a cross 
section of the A6 population. A few Ad units were isolated for which 
no receptive field was found. These never represented more than 8% of 
the A6 population in any given treatment group including controls and 
were excluded from the analysis. Receptive fields were found for all A/3 
afferents. 
At the end of an experiment, some animals were perfused through 
the heart with warm saline followed by 2% paraformaldehyde. L5 and 
L5 dorsal root ganglia were removed, postfixed overnight, and stored 
in 30% sucrose. Frozen 30 pm sections were cut and stained with cresyl 
violet, and raw profile counts were made from the ganglia. In this par- 
ticular strain of rats (Sprague-Dawley, Taconic Farms, Germantown, 
NY), only these two ganglia contributed to the sciatic nerve. In every 
animal, the contributions of L4 and L5 to the sciatic varied: usually, 
the L4 ganglion was larger than the L5 ganglion, but sometimes they 
were nearly equal in size. To minimize this particular source of vari- 
ability, counts from the two ganglia were pooled and counted as a single 
unit. This strategy has been shown to minimize bilateral asymmetries 
in sensory neuron counts (Ygge et al., 198 1). Approximately 10% of the 
profiles randomly distributed through the two ganglia were drawn with 
the aid of a drawing tube, and mean profile diameters were measured 
on a digitizing tablet connected to the Eutectics neuron reconstruction 
system. A correction factor for the raw counts was calculated from the 
profile diameters using recursive translation (Rose and Rohrlich, 1987; 
McMahon et al., 1991). This is a mathematical correction factor for 
double counting that has certain advantages for the purposes of this 
study. The correction factor for any one ganglion is scaled according to 
the size distribution of cells present. Thus, a selective loss of small cells, 
for example, leads to an automatic compensatory change in the correc- 
tion factor. The recursive translation program produces a reconstructed 
cell-size histogram based on the distribution of neuronal profiles present. 
This enabled us to demonstrate a selective loss of small cells after anti- 
NGF treatment (see Fig. 3). 
A total of 166 Aj3 afferents and 35 1 A6 afferents were recorded from 
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Figure 2. Plot ofnumbers ofunits broken down by receptor type versus 
conduction velocity. It will be noticed that HTMRs conducting in the 
A6 range are markedly depleted after anti-NGF treatment and appear 
to be replaced by hair follicle afferents (HAIR), in this case D-hair 
afferents. Within the A@ range most afferents were hair follicle afferents 
(HAIR), and this remained the case after anti-NGF treatment. Anti- 
NGF did not appear to affect the proportions or conduction velocities 
of the minority A@ afferents such as Pacinian corpuscle afferents (PC), 
low-threshold slowly adapting afferents (SAI and SAII) (LTSA) or field 
receptors (FIELD) found in the sural nerve (see Table 1 for more details). 
For these experiments, a total of 99 units were recorded in control 
animals and 105 units in anti-NGF-treated animals. 
and fully characterized in these experiments. All means quoted in the 
text are given together with their standard deviations. 
Results 
Physiology of A/l aferents 
Table 1 illustrates the percentages of different types of cutaneous 
AP afferents in control animals and in those treated from birth 
to 5 weeks with anti-NGF. The latter group was an amalgam- 
ation of data from animals that were treated with antiserum up 
until the time of recording at 5 weeks of age (n = 5) and from 
animals that were treated for 5 weeks and allowed to survive 
without treatment for an additional 3 weeks before recording 
(n = 3). These data were pooled since no significant differences 
were seen between these two groups in the proportions or the 
physiology of A/3 or A6 afferents. When the data from anti- 
NGF-treated animals are compared to control data, it can be 
seen that the proportions of hair follicle afferents and other 
cutaneous afferents (field receptors, slowly adapting type I, Pa- 
cinian corpuscles, and AD HTMRs) were very similar, differing 
by only 11% in the case of hair follicle afferents and by no more 
than 6% for any of the other afferent types listed above @ > 
0.3, x2). Physiological parameters ofcutaneous afferents (see Fig. 
1) such as receptive field size, location, response to natural stim- 
ulation, and von Frey thresholds (Table 1) were indistinguish- 
able from controls. Table 1 includes only cutaneous units; units 
with subcutaneous receptive fields, that is, “deep” units, ac- 
counted for about a third of the total A@ afferents sampled, 28% 
in control and 32% in anti-NGF-treated animals. These A/3 
“deep” units were often low threshold and slowly adapting. 
Mean conduction velocities for Ap afferents were remarkably 
similar in control and anti-NGF-treated animals (Table 1). This 
is further illustrated in Figure 2, which shows the conduction 
velocity of all cutaneous units broken down by afferent type. 
Control and anti-NGF histograms differ only in the virtually 
complete depletion of A6 cutaneous HTMRs from the treated 
groups; A@ afferents are represented in similar proportions and 
at similar conduction velocities in both groups. This is in agree- 
ment with the finding that chronic anti-NGF treatment does 
not change the distribution of myelinated axon diameters in the 
sural nerve (Ritter et al., 199 1). 
Lack of correlation with cell death 
We have previously demonstrated that treatment of rats with 
antisera beginning at 2 weeks of age does not produce the change 
in physiology seen after treatment beginning on the day of birth 
(Ritter et al., 1991; see also Fig. 5). This implies that it should 
be possible to create a deficit of cutaneous HTMRs by treatment 
only in the first two postnatal weeks. Indeed, treatment with 
Table 1. Physiology of A@ afferents 
Control Anti-NGF 
Mean CV von Frey Mean CV von Frey 
% Total (m/set) threshold (g) % T&al (m/set) threshold (g) 
Hair follicle afferent 58.8%(30/51) 22.9 + 5.3 0.05 k 0.08 69.3%(43/62) 22.5 + 6.0 0.05 + 0.08 
Slowly adapting (SAI and SAII) 5.9%(3/51) 24.2 f  5.1 0.07 f  0.0 9.7%(6/62) 26.6 + 6.0 0.05 + 0.02 
Field 17.6% (915 1) 24.0 +- 5.8 0.19 + 0.2 12.9%(8/62) 24.4 + 4.6 0.38 + 0.27 
Pacinian corpuscle 12% (6151) 23.8 k 4.0 NA 6.5%(4/62) 28.7 + 6.2 NA 
AD HTMR 5.9%(3/51) 20.1 f  4.3 11.88(n = 1) 1.6% (l/62) 23.4 11.8 
CV, conduction velocity; NA, not applicable. 
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Figure 3. A-C are distributions of receptor type versus conduction velocity of A6 afferents from control and PND O-14 and PND 2-14 anti- 
NGF-treated groups, respectively. The populations of afferents in animals tested from PND 0 to 14 and PND 2 to 14 were significantly different 
from the population in control animals (p < 0.01, x2). For control, n = 9 animals, and for PND O-14 and PND 2-14, n = 3 each. D-F are cell- 
size histograms generated by recursive translation for control and PND O-14 and PND 2-14 treated groups, respectively. G is a graph of mean cell 
counts pooled from L4 and L5 dorsal root ganglia from animals treated as indicated. Counts were made from ganglia from both sides of each 
animal. For control, n = 5 animals, for PND O-14, n = 6 animals, and for PND 2-14, II = 5 animals. Note that anti-NGF treatment from PND 
0 to 14 and 2 to 14 produces essentially the same depletion of HTMRs from the sural nerve (A-c). Treatment beginning at birth leads to a significant 
loss of sensory neurons from the L4 and L5 ganglia (G), which appeared to be specific for small neurons. In contrast, anti-NGF treatment from 
PND 2 to 14 produced no significant cell death (F and G) even though HTMRs were similarly depleted from the nerve (C). 
antisera from PND 0 to PND 14 caused a loss of cutaneous 
HTMRs similar to, although not as extensive as, that seen in 
chronically treated animals (O-5 weeks; see Fig. 2). In control 
animals, cutaneous HTMRs represent the largest proportion of 
the A6 population, constituting 4 1% of the total sample. D-hairs 
make up 29% of the sample, and the remaining 30% are “deep” 
units that innervate subcutaneous tissue (Fig. 3A). After anti- 
NGF treatment from 0 to 14 d, cutaneous HTMRs represented 
only 13%‘of the total A6 population. The proportion of D-hairs 
had increased to 5 l%, while deep units remained little changed 
at 36% (Fig. 3B). 
It was found that anti-NGF treatment beginning on the day 
of birth resulted in a significant decrease in the number of DRG 
cells. This loss of 20% (p < 0.05, unpaired t test) (Fig. 3G) is 
similar to results obtained by others (Yip et al., 1984). It is 
evident from the large SE bars in Figure 3G that these cell counts 
were highly variable. This variability arose from two sources. 
First, counts from animal to animal, even in controls, were 
variable. Second, the cell death induced by anti-NGF did not 
occur in all cases. In some cases, cell counts from ganglia from 
one side of a treated animal were close to the mean for control 
animals, but on the contralateral side the number of cells could 
be reduced by half. In addition, in one animal the number of 
cells present after anti-NGF was essentially the same as found 
in controls. This suggested to us that these cells may not be 
sensitive to NGF deprivation for long after birth, and that per- 
haps small differences in the ages of animals at the onset of anti- 
NGF administration can lead to large differences in the amount 
of anti-NGF induced cell death. 
The cell size histograms (Fig. 3&F) from each treatment 
group exhibit a clear bimodal distribution, with a large peak 
presumably corresponding to the small sized C-neurons and a 
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Figure 4. Histograms of receptor type of A6 afferents versus conduction velocity for control and anti-NGF-treated animals. For control, n = 9, 
and for all other groups, n = 3. Cutaneous HTMRs are significantly reduced in animals treated from PND 4 to 11 (p < 0.0 1, x2) but not in animals 
treated from PND 2 to 9 or PND 7 to 14 (p > 0.2, x2). Thus, a 7 d anti-NGF treatment within the first 2 postnatal weeks is only fully effective 
when given between PND 4 and 11 and not when given earlier (PND 2-9) or later (PND 7-14) in development. 
smaller peak corresponding to the larger A-neurons (Lawson, 
1979; Lawson et al., 1984). The cell loss from the O-l 4 d treated 
animals seems to be restricted to the first peak and probably 
represents a loss of C-neurons (Harper and Lawson, 1985; Fig. 
3E). 
Anti-NGF treatment beginning later, on PND 2-l 4, produced 
a deficit in cutaneous HTMRs almost identical to that seen in 
animals treated from PND 0 to 14. Cutaneous HTMRs repre- 
sented only 16% of the sural nerve A6 population in these an- 
imals (Fig. 3c). However, this treatment produced no discem- 
ible cell death since cell counts from PND 2-l 4 d treated animals 
did not differ from those in control animals (p > 0.5, unpaired 
t test) (Fig. 3G). The fact that identical physiology is obtained 
with or without a 20% loss of cells leads us to conclude that the 
changes in physiology seen here are not correlated with cell death 
produced by anti-NGF treatment. 
Critical period 
Treatments were given for discrete 7 d periods during the first 
two postnatal weeks in an effort to determine more precisely 
when this change could be produced, that is, a developmental 
critical period. Figure 4 illustrates that treatment late in the 
postnatal period, from PND 7 to 14, was ineffective at producing 
a deficit in cutaneous HTMRs. The proportions of units in these 
animals (38% HTMRs, 34% D-hairs, and 28% “deep” units) 
were similar to the proportions in control animals. Likewise, 
treatment early in the postnatal period, from PND 2 to 9, did 
not significantly (p > 0.2, x2) change the proportions of A6 
afferents, although there was a somewhat larger (but statistically 
insignificant) drop in the proportion of cutaneous HTMRs, down 
to 29%. Surprisingly, treatment from PND 4 to 11 was sufficient 
to reduce the proportion of cutaneous HTMRs to 16%, which 
is very similar to the deficit produced in animals treated from 
PND 0 to 14 and PND 2 to 14. 
A summary of all the treatment groups is illustrated in Figure 
5. From this figure, it is evident that across all treatment groups, 
the proportion of “deep” units remains constant, between 28% 
and 36%. If cutaneous HTMRs were simply disappearing, or 
slowing their conduction velocity to become C-fibers (and there- 
fore not being sampled), one might expect the proportions of 
“deep” units and D-hair afferents to rise equally. Instead, in 
every instance where there was a drop in the proportion of 
cutaneous HTMRs, there was a corresponding rise in the pro- 
portion of D-hair afferents, with no change in the proportion of 
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“deep” units. Thus, it appears that D-hair afferents replace the 
missing HTMRs. 
Physiology of A6 afferents 
The physiology of D-hair afferents and “deep” units recorded 
in anti-NGF-treated animals did not differ from that in control 
animals. D-hairs in normal animals were extremely sensitive, 
having von Frey thresholds that averaged only 0.0 1 + 0.02 gm. 
These units were activated by seemingly all of the hairs within 
the receptive field, gave a brisk response to hair movement, and 
often were sensitive enough to be activated by small movements 
of the skin at sites distant from the receptive field. D-hair af- 
ferents in all of the anti-NGF-treated groups (both effective 
treatments and ineffective treatments) were normal, having von 
Frey thresholds averaging 0.0 1 + 0.02 gm and responding iden- 
tically to natural stimulation as D-hairs in controls. Neither the 
sizes nor the spatial distributions of the receptive fields on the 
limb in the anti-NGF-treated animals differed from those in 
control animals. 
Units with subcutaneous receptive fields, “deep” units, in 
control animals were usually high threshold, requiring frankly 
noxious stimulation of deep tissues or joints to evoke a response. 
These units could be either slowly or rapidly adapting, and the 
rapidly adapting units tended to have particularly high thresh- 
olds. Care was taken to distinguish “deep” units requiring ma- 
nipulation of the underlying tissue to produce a response. After 
anti-NGF treatment, “deep” units were qualitatively the same 
as in controls and still were largely high threshold. 
A6 cutaneous HTMRs have been described in detail in the 
cat (Burgess and Perl, 1967) and in the rat (Lynn and Carpenter, 
1982) and the physiology of these units observed in our ex- 
periments was very similar. In control animals, the majority of 
cutaneous HTMRs (79%) were slowly adapting and the recep- 
in the percentage of D^-hair afferents. 
This happened in the absence of any 
consistent effect on the proportion of 
“deep” afferents. 
tive fields of these contained a number of sensitive spots. Rap- 
idly adapting units represented the remaining 2 1% of the HTMR 
population and were extremely insensitive, having mean von 
Frey thresholds of 54 + 49 gm, compared to 4.3 + 2.3 gm for 
the slowly adapting units. Rapidly adapting units often desen- 
sitized rapidly or gave such a sluggish response to natural stim- 
ulation (one or two spikes to intense pinching of the receptive 
field) that determination of von Frey thresholds was often prob- 
lematic. 
In order to compare the physiology of cutaneous HTMRs 
after anti-NGF treatment, animals were subdivided into two 
categories, those in which anti-NGF treatment produced a loss 
of cutaneous HTMRs (designated “effective” in Fig. 6) and those 
in which anti-NGF treatments were without effect (designated 
“ineffective” in Fig. 6). Anti-NGF treatment that did not result 
in a deficit in HTMRs did not change the physiology of the 
HTMRs. The percentages of slowly and rapidly adapting units 
were 76% and 24%, respectively, the same as in controls. The 
von Frey thresholds for both the rapidly adapting units (45 f 
50 gm) and the slowly adapting units (6.0 + 4.8 gm) were un- 
changed. The cumulative sum distribution of thresholds for 
slowly adapting units is illustrated in Figure 6, and this distri- 
bution is identical to that of controls. 
In contrast, anti-NGF treatments that caused a reduction in 
the proportion of HTMRs resulted in a change in the physiology 
of the remaining HTMRs. The proportion of HTMRs that were 
slowly adapting increased to 9 1%. Only 2 rapidly adapting units 
were found out of a total of 23, and both of these were found 
in animals treated from PND 4 to 11, the briefest effective 
treatment. The mechanical thresholds of the slowly adapting 
units were greater than in controls, averaging 9.5 + 6.7 gm (Fig. 
6). The cumulative sum distribution for these units was shifted 
to the right of both control and ineffective anti-NGF treated 
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Figure 6. Cumulative sum distributions of mechanical thresholds of 
slowly adapting HTMRs from control and anti-NGF-treated animals 
measured with calibrated von Frey hairs. “Ineffective” treatments refer 
to those anti-NGF treatments that did not significantly reduce the num- 
ber of HTMRs, and include PND 2-9, PND 7-14, and 2-5 week treat- 
ments. “Effective” treatments include PND 4-l 1, PND O-14, PND 2- 
14, O-5 week, and O-5 week plus wait groups. Mechanical thresholds 
are significantly elevated in cutaneous HTMRs from “effective” treat- 
ment groups (p < 0.001, Kolmogorov-Smimov) but not in cutaneous 
HTMRs from “ineffective” treatment groups (p > 0.3, Kolmogorov- 
Smirnov). 
animals. Thus, not only was there a large decrease in the number 
of HTMRs after anti-NGF treatment, but the few that remained 
were less sensitive as well. 
Discussion 
We have demonstrated that NGF deprivation during a brief 
critical period results in a deficit in cutaneous HTMRs and an 
increase in the mechanical thresholds of those HTMRs that 
remain. Concomitantly, there is an increase in the number of 
sensitive D-hair afferents. Since this change in the population 
of cutaneous afferents can occur in the absence of anti-NGF- 
induced cell death, we interpret it as switching of developing 
afferents from HTMRs into D-hairs. 
The strength of the interpretation of this change as a phe- 
notypic switch rather than a change caused by cell death rests 
on the fact that the phenomenology remains the same whether 
there is a large amount of cell death (O-14 d treatment) or no 
detectable cell death (2-l 4 d treatment). However, we concede 
that if cutaneous HTMRs made up only 5% of the cells in the 
ganglia, and if only all of those died in the 2-14 d treatment, 
the large variability in these cell counts would make it possible 
to miss such a loss. If this were the case, it would imply these 
particular A6 neurons are more susceptible to NGF deprivation 
than the smaller C-neurons; this seems unlikely. The finding 
that the percentage of D-hairs increases as the percentage of 
HTMRs decreases suggests that HTMRs do not die, but become 
D-hairs, since, if only HTMRs died, one would expect to sample 
roughly equal numbers of D-hairs and “deep” units as is the 
case in controls. Instead, one finds D-hairs and “deep” units at 
a ratio of roughly 2: 1. This might be explained if some “deep” 
units die in addition to HTMRs, and the two types of cells are 
lost at some fixed ratio such that the proportion of “deep” units 
is decreased relative to D-hairs. However, such a mechanism 
would require a level of death of A6 neurons large enough to be 
detectable in cell counts. Perhaps the most compelling argument 
against cell death as a mechanism is the fact that anti-NGF 
treatment from PND 4 to 11 produces a more profound less of 
cutaneous HTMRs than a treatment of the same duration be- 
ginning earlier, from PND 2 to 9. Since the dependence of 
sensory neurons on NGF decreases with developmental age 
(Greene, 1977b), this result is inconsistent with the idea that 
the decrease in HTMRs is due to cell death. 
It is possible that anti-NGF leads to the observed loss of 
HTMRs in the absence of cell death by specifically interfering 
with their development, by preventing either their myelination 
or the development of their receptor endings. Both these pos- 
sibilities are operationally similar to cell death in that one would 
expect to see a selective loss of A6 fibers from the sural nerve 
and increased numbers of both deep and D-hair afferents (see 
above). These effects were never observed (Ritter et al., 199 1). 
Furthermore, there was no increase in the proportion of units 
with no receptive field in anti-NGF-treated animals as might 
have been expected if receptor development had been prevent- 
ed. In a recent study of C-fiber afferents after anti-NGF treat- 
ment (PND 2-14), no units were found with receptive fields 
resembling A6 HTMRs (G. R. Lewin and L. M. Mendell, un- 
published observations). Thus, we feel that it is very unlikely 
that anti-NGF treatments deplete A6 HTMRs by interfering 
with myelin or receptor formation in the first 2 postnatal weeks. 
The change in the composition of the A6 primary afferent 
population can be evoked by a relatively brief treatment over 
a critical period within the first two postnatal weeks. However, 
the deficit in cutaneous HTMRs observed after a brief neonatal 
treatment is not as great as that observed after chronic anti- 
NGF treatment from 0 to 5 weeks. Several explanations can be 
offered for this discrepancy. The HTMRs that remain in the 
briefly treated neonatal group are among the slowest conducting 
afferents sampled (around half have conduction velocities less 
than 4 m/set). Therefore, the larger numbers of HTMRs seen 
in animals subjected to brief treatment (15% of the total com- 
pared to 5% in the chronically treated animals) might simply 
be due to sampling larger numbers of slow units in these treat- 
ment groups. Alternatively, there could be some small recovery 
in the neonatally treated animals: treatment was ceased on PND 
14, but recordings were not carried out until the animals had 
reached maturity, sometimes 4 or 5 weeks later. A third expla- 
nation would be that treatment is required beyond PND 14 to 
produce a maximal effect. 
The additional finding that anti-NGF treatment can raise the 
mechanical threshold of cutaneous HTMRs under some cir- 
cumstances is complicated by the fact that this occurs only in 
cases where the proportion of HTMRs is drastically reduced. 
Therefore, from these data it is not clear whether NGF has a 
direct effect on mechanical threshold, or whether the HTMRs 
that are “spared” represent a population that have higher thresh- 
olds than the population at large. However, in preliminary ex- 
periments we have found that treatment with exogenous NGF 
during the first 2 weeks can lower the mechanical threshold of 
cutaneous HTMRs (&win et al., 1991b). This would suggest a 
direct role for NGF in regulating mechanical threshold, but only 
during restricted periods in development. 
The dosage regime we have chosen here produced a degree 
of sensory neuron cell death very similar to that of the regime 
used by Yip et al. (1984). This is despite the fact that they 
injected five times as much antisera during PND O-7. Thus, we 
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believe that the dosages we have used in these experiments are 
probably supramaximal for the effects we have seen, although 
we have no direct evidence that this is the case. 
We believe the effects demonstrated here to be due specifically 
to a reduction in levels of NGF rather than in levels of any of 
the other members of the neurotrophin family. We have not 
explicitly tested our antisera for cross-reactivity with any of 
these other factors, but the known pattern of expression of NGF 
compared with that of NT-3 and brain-derived neurotrophic 
factor (BDNF) makes it likely that the effect seen here is me- 
diated by NGF rather than by one of the related neurotrophic 
molecules. NGF and BDNF have been shown to support par- 
tially overlapping populations of sensory neurons in vitro (Lind- 
say et al., 1985), but levels of BDNF mRNA are low to unde- 
tectable in skin (Maisonpierre et al., 1990a,b). This would seem 
to rule out a crucial role for BDNF in the development of cu- 
taneous innervation. NT-3 mRNA exists in high concentrations 
in skin but also is found in high concentrations in skeletal muscle 
and a variety of other non-neuronal tissues (Hohn et al., 1990; 
Maisonpierre et al., 1990a,b). Given this distribution, it would 
be difficult to explain how a factor affecting neurons innervating 
cutaneous but not those supplying subcutaneous structures could 
be NT-3. In contrast, levels of NGF and its message are high 
in skin and low in skeletal muscle (Korsching and Thoenen, 
1983; Goedert et al., 1986; Davies et al., 1987), making it the 
most appropriately localized neurotrophic factor to mediate the 
stabilization of HTMRs described here. 
A possible mechanism by which developing HTMRs might 
be induced to innervate hair follicles when NGF levels are low- 
ered by antisera treatment is suggested by the sequence of events 
that occurs as sensory axons innervate skin. In the rat, sensory 
axons grow out to the skin beginning around E13-E15. Axons 
reach trunk skin by El3 but do not reach the most distal skin 
in the toes until as late as E 19 (Reynolds et al., 199 1). Sensory 
axons do not immediately innervate targets in the skin but form 
a dense plexus in the epidermis that persists for the next several 
days (Fitzgerald, 1967; Reynolds et al., 1991). Most of these 
fibers then withdraw from the epidermis between PND 5 and 
10 to innervate structures such as hair follicles in the dermis, 
with withdrawal of more rostra1 innervation occurring in ad- 
vance of that of more caudal innervation. Some fibers remain 
in the epidermis in adulthood, and a proportion of these are 
believed to be the anatomical substrates of A6 cutaneous HTMRs 
(Kruger et al., 198 1). Interestingly, it has been found that levels 
of NGF mRNA are more concentrated in the epidermis than 
in the dermis, at least in the embryo (Davies et al., 1987). We 
suggest that a relatively high level of NGF in the epidermis is 
necessary to stabilize the projection of developing A6 HTMRs, 
and that in its absence these cells do not die but withdraw to 
the dermis to innervate hair follicles. 
A schematic diagram of the timing of skin innervation and 
the withdrawal of fibers from the epidermis is illustrated in 
Figure 7, and with it are shown the periods of time over which 
anti-NGF treatments were given. Only those injection periods 
that completely overlap the period of fiber withdrawal (PND 
5-10) are effective in significantly reducing the numbers of cu- 
taneous HTMRs. Anti-NGF treatment from PND 2 to 9 covers 
almost all the putative critical period and may produce a small 
loss of A6 HTMRs. However, NGF deprivation limited to the 
period between PND 4 and 11 is sufficient to produce a depletion 
of HTMRs equal to that found with anti-NGF treatments from 
PND 0 to 14 and 2 to 14. Thus, it appears that NGF deprivation 
over the whole period of fiber withdrawal is necessary to produce 
the full effect. 
If the phenomenon demonstrated here does represent a phe- 
notypic switch, it would not be the first such demonstration in 
a neural crest derivative. Developing sympathetic neurons ex- 
press noradrenergic markers when they initially innervate sweat 
glands, but are induced to switch to a cholinergic phenotype by 
a factor or factors present in the target tissue (reviewed in Landis, 
1990). Here, the role for NGF in promoting the switch from 
HTMR to D-hair is not an instructive one. The presence of 
NGF would serve to provide a hospitable environment for de- 
veloping HTMRs, with the actual switch being brought about 
by factors present in the dermis or produced by hair follicles. 
That this may represent a real switch in phenotype rather than 
just an exchange of targets is suggested by the following. Somal 
spikes recorded intracellularly from dorsal root ganglion cells 
innervating D-hairs in anti-NGF O-5 week treated animals all 
displayed the short-duration spike with a simple falling phase 
characteristic of these cells in normal animals. None was seen 
with the larger-amplitude, longer-duration spike with a biphasic 
falling phase that is characteristic of HTMRs (Ritter, 1991). 
Thus, at least this aspect of cell phenotype is in register with 
the target innervated. 
The absence of cell death, the high correlation between the 
“critical period” for this effect and the timing of withdrawal of 
fibers from the epidermis, and the increase in the proportions 
of D-hairs all strongly support the notion of a change in devel- 
opmental fate of HTMRs induced by NGF deprivation. Al- 
though the coincidence in timing between the physiological 
change and the anatomical change is striking, we have no direct 
evidence that the two are connected. Clearly, anatomical evi- 
dence will be needed to add further support for this hypothesis. 
Experiments are in progress to examine peptide staining in the 
skin and the ganglia after anti-NGF treatments. Indeed, prelim- 
inary studies show fibers immunoreactive for calcitonin gene- 
related peptide in the epidermis to be reduced in number after 
anti-NGF treatment (G.R. Lewin, J.R. Tonra, S.B. McMahon, 
and L.M. Mendell, unpublished observations). 
The importance of NGF for cell survival during embryonic 
and early postnatal periods has been well documented (Barde, 
1989). By the time animals have reached adulthood, periph- 
erally derived NGF is no longer important as a survival factor 
in the intact animal (however, see Johnson and Yip, 1985, for 
a discussion of centrally derived NGF). In the adult, NGF still 
regulates some aspects of sensory neuron function, in particular 
neuropeptide levels (Mayer et al., 1982), indicating that as an- 
imals mature the function of NGF changes. Our findings indi- 
cate that the ability of anti-NGF treatment to cause cell death 
ends by PND 2. Beyond PND 2, but within a time frame during 
which the innervation of skin is still developing, we demonstrate 
that NGF is capable of influencing the character of skin inner- 
vation. Thus, as animals continue to mature, a different role for 
NGF is revealed, restricted to a short period during develop- 
ment and independent of the effects of NGF on cell survival. 
Conclusions 
We have presented evidence to suggest that NGF deprivation 
can induce a phenotypic switch in developing primary afferents. 
This switch, from an HTMR (A&) to a low-threshold mecha- 
noreceptor (D-hair), can occur in the absence of anti-NGF- 
induced cell death and is restricted to a critical period in early 
postnatal life corresponding to a time when there is an anatom- 
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Figure 7. Summary of the timing of effective and ineffective anti-NGF treatments in relation to the timing of anatomical changes in skin innervation. 
Note that treatments are designated ineffective when there was no statistically significant decrease in the number of HTMRs found in the sural 
nerve. 
ical change in skin innervation. This finding implies that the 
phenotype of this population of thinly myelinated afferents is 
not irreversibly specified at birth, and that these afferents require 
information from the periphery in order to stabilize their iden- 
tities. One can only speculate about the nature of this infor- 
mation, whether it is a factor derived from the dermis or from 
the hair follicle, and whether there are perhaps other factors 
associated with different types of afferents. The fate ofthe central 
projections of these converted afferents remains as yet unknown. 
Further experiments are under way to determine whether their 
central terminations have arranged themselves to become ap- 
propriate anatomically and functionally to their new targets. 
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